Andere Sprachen Jiuzhitang Co., Ltd.

Aktien

000989

CNE000001394

000989

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 07.06.2024			% 5 Tage	% 1. Jan.
6.9 ^CNY	+2.07%		+3.45%	-31.82%

20.05.	Jiuzhitang Co., Ltd. beschließt endgültige Bardividende für das Jahr 2023	CI
25.04.	Jiuzhitang Co., Ltd. schlägt endgültige Bardividende (inkl. Steuern) für 2023 vor	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Jiuzhitang Co., Ltd. Approves Final Cash Dividend for the Year 2023	20.05.
Jiuzhitang Co., Ltd.(XSEC:000989) dropped from S&P Global BMI Index	08.05.
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	25.04.
Jiuzhitang Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24.04.
Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.	02.04.
Jiuzhitang Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	18.03.
Jiuzhitang Co., Ltd. authorizes a Buyback Plan.	18.03.
Jiuzhitang's Unit to Launch Clinical Trials Into Human Bone Marrow Stem Cell Injection; Shares Drop 3%	02.11.
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25.10.23
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	08.08.23
Jiuzhitang Unit to Hold Clinical Trial Into Stem Cell Treatment	12.06.23
Jiuzhitang Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023	30.05.23
Jiuzhitang Co., Ltd. Approves Cash Dividend for the Year 2022	25.05.23
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend for 2022	04.05.23
Jiuzhitang Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28.04.23
Jiuzhitang Co., Ltd. Appoints Bo Jinfeng as Non-Independent Director	11.01.23
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27.10.22
Jiuzhitang Cleared to Launch Clinical Trial of Deep Vein Thrombosis Drug	22.09.22
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30.08.22
Jiuzhitang Co., Ltd. Appoints Wang Yonghui as a Non-Independent Director	17.08.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Jiuzhitang Co., Ltd.

Aktien

000989

CNE000001394

000989

Andere Sprachen

Filter